RA=rheumatoid arthritis.

References: 1. Schett G, Coates LC, Ash ZR, Finzel S, Conaghan PG. Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: traditional views, novel insights gained from TNF blockade, and concepts for the future. Arthritis Res Ther. 2011;13(suppl 1):S4. 2. National Psoriasis Foundation. Statistics. http://www.psoriasis.org/research/science-of-psoriasis/statistics. Accessed March 3, 2015. 3. Helmick CG, Felson DT, Lawrence RC, et al; for the National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008;58(1):15-25. 4. Akkoc N. Are spondyloarthropathies as common as rheumatoid arthritis worldwide? A review. Curr Rheumatol Rep. 2008;10(5):371-378. 5. Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569-2581. 6. Lories RJ, Baeten DL. Differences in pathophysiology between rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol. 2009;27(4 suppl 55):S10-S14. 7. Braun J, Sieper J. Ankylosing spondylitis. Lancet. 2007;369(9570):1379-1390. 8. Lories RJ, Luyten FP, de Vlam K. Progress in spondylarthritis: mechanisms of new bone formation in spondyloarthritis. Arthritis Res Ther. 2009;11(2):221. 9. Haroon M, Kirby B, FitzGerald O. High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires. Ann Rheum Dis. 2013;72(5):736-740. 10. Rudwaleit M, Khan MA, Sieper J. The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum. 2005;52(4):1000-1008. 11. Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, Braun J. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int. 2003;23(2):61-66. 12. Cross MJ, Smith EU, Zochling J, March LM. Differences and similarities between ankylosing spondylitis and rheumatoid arthritis: epidemiology. Clin Exp Rheumatol. 2009;27(4 suppl 55):S36-S42. 13. Centers for Disease Control and Prevention. Rheumatoid arthritis. 2011. http://www.cdc.gov/arthritis/basics/rheumatoid.htm. Accessed July 16, 2015. 14. National Psoriasis Foundation. Facts about psoriatic arthritis. National Psoriasis Foundation website. https://www.psoriasis.org/Doent.Doc?id=1493. Accessed September 17, 2015. 15. Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005;64(suppl 2):ii14-ii17. 16. Chen H-H, Chen T-J, Chen Y-M, Ying-Ming C, Chen D-Y. Gender differences in ankylosing spondylitis-associated cumulative healthcare utilization: a population-based cohort study. Clinics. 2011;66(2):251-254. 17. Veale D, Rogers S, FitzGerald O. Classification of clinical subsets in psoriatic arthritis. Br J Rheumatol. 1994;33(2):133-138. 18. Kane D, Stafford L, Bresnihan B, FitzGerald O. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology. 2003;42(12):1460-1468. 19. Sokoll KB, Helliwell PS. Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. J Rheumatol. 2001;28(8):1842-1846. 20. Lee S, Mendelsohn A, Sarnes E. The burden of psoriatic arthritis: a literature review from a global health systems perspective. P T. 2010;35(12):680-689. 21. Rahman P, Nguyen E, Cheung C, Schentag CT, Gladman DD. Comparison of radiological severity in psoriatic arthritis and rheumatoid arthritis. J Rheumatol. 2001;28(5):1041-1044. 22. Williamson L, Dalbeth N, Dockerty JL, Gee BC, Weatherall R, Wordsworth BP. Extended report: nail disease in psoriatic arthritis—clinically important, potentially treatable and often overlooked. Rheumatology. 2004;43(6):790-794. 23. McHugh NJ, Balachrishnan C, Jones SM. Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study. Rheumatology. 2003;42(6):778-783. 24. Haroon M, Gallagher P, FitzGerald O. Diagnostic delay of even more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis [abstract]. Arthritis Rheum. 2013;65(suppl 10):309. 25. Ward MM, Reveille JD, Learch TJ, Davis JC Jr, Weisman MH. Impact of ankylosing spondylitis on work and family life: comparisons with the US population. Arthritis Rheum. 2008;59(4):497-503. 26. Rudwaleit M, Haibel H, Baraliakos X, et al. The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum. 2009;60(3):717-727. 27. Rojas-Vargas M, Muñoz-Gomariz E, Escudero A, et al. First signs and symptoms of spondyloarthritis—data from an inception cohort with a disease course of two years or less (REGISPONSER-Early). Rheumatology. 2009;48(4):404-409. 28. Paparo F, Revelli M, Semprini A, et al. Seronegative spondyloarthropathies: what radiologists should know. Radiol Med. 2014;119(3):156-163. 29. Cooper C, Carbone L, Michet CJ, Atkinson EJ, O'Fallon WM, Melton LJ III. Fracture risk in patients with ankylosing spondylitis: a population based study. J Rheumatol. 1994;21(10):1877-1882.